Ozempic (semaglutide) is prescribed for adults with type 2 diabetes. The drug is given as an injection under the skin once per week. Doctors usually prescribe a starting dose and a maintenance dose.

SURPASS-2 was an open label, 40-week, phase-3 trial which randomized patients to receive once-weekly injections of Mounjaro at a dose of 5 mg, 10 mg, or 15 mg, or Ozempic at a dose of 1 mg.

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Novo Nordisk’s once‐weekly injectable, Ozempic (semaglutide), originally developed for type 2 diabetes, has increasingly ...

“If someone is making other changes to their nutritional intake or their exercise routine and they’re using psyllium husk as ...

Australians and health professionals are being warned to check the legitimacy of Ozempic products after a batch of illegal counterfeit injection pens was detected at the Australian border. The type of ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

As with other drugs, Ozempic (semaglutide) can cause side effects, such as nausea and dizziness. If you are not able to tolerate side effects of Ozempic, talk with your doctor or pharmacist.

Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from STRIDE, a phase 3b peripheral artery disease (PAD) outcomes trial investigating the effects of once-weekly ...